Translating The Foreign Corrupt Practices Act Into Practice: DoJ/SEC Offer Pragmatic Enforcement Guide
This article was originally published in The Pink Sheet Daily
Executive Summary
The FCPA resource guide gives examples of cases the DoJ and SEC have decided not to prosecute and describes the hallmarks of an effective compliance program; PhRMA, GPhA among groups that were asking for more clarity.
You may also be interested in...
Pfizer Settles Foreign Bribery Charges, Wins Deferred Prosecution For Helping Government
Pfizer reaches separate settlements with DoJ and SEC to resolve charges its subsidiaries bribed foreign government officials; a subsidiary enters a deferred prosecution agreement with DoJ.
J&J Takes The Lead In Settling SEC/DoJ Foreign Corrupt Practices Act Probe
The government charged J&J with bribing doctors in Greece, Poland and Romania to order or prescribe its products; the $70 million settlement includes a deferred prosecution agreement.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.